Penumbra (PEN) Return on Capital Employed Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 866.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 866.00 |
| Dec 31, 2025 | 1,112.00 |
| Sep 30, 2025 | 1,111.00 |
| Jun 30, 2025 | 1,230.00 |
| Mar 31, 2025 | -281.00 |
| Dec 31, 2024 | -471.00 |
| Sep 30, 2024 | -321.00 |
| Jun 30, 2024 | -436.00 |
| Mar 31, 2024 | 402.00 |
| Dec 31, 2023 | 490.00 |
| Sep 30, 2023 | 659.00 |
| Jun 30, 2023 | 588.00 |
| Mar 31, 2023 | 365.00 |
| Dec 31, 2022 | 127.00 |
| Mar 31, 2022 | 143.00 |
| Dec 31, 2021 | 472.00 |
| Mar 31, 2021 | -1,003.00 |
| Dec 31, 2020 | -1,413.00 |
| Sep 30, 2020 | -1,236.00 |
| Jun 30, 2020 | -92.00 |
| Mar 31, 2020 | 508.00 |
| Dec 31, 2019 | 885.00 |
| Sep 30, 2019 | 933.00 |
| Jun 30, 2019 | -209.00 |
| Mar 31, 2019 | -35.00 |
| Dec 31, 2018 | -47.00 |
| Sep 30, 2018 | 15.00 |
| Jun 30, 2018 | 557.00 |
| Mar 31, 2018 | 329.00 |
| Dec 31, 2017 | 79.00 |
| Sep 30, 2017 | -163.00 |
| Jun 30, 2017 | -364.00 |
| Mar 31, 2017 | -247.00 |
| Dec 31, 2016 | -230.00 |